Journal of Research in Medical Sciences

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 22  |  Issue : 1  |  Page : 49-

Serum enolase-2, high-sensitivity C-reactive protein, and serum cholesterol in smear-positive drug-naïve pulmonary tuberculosis


Suhail Ahmed Almani1, Tariq Zaffar Shaikh1, Haji Khan Khoharo2, Ikramuddin Ujjan3 
1 Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
2 Faculty of Medicine and Allied Medical Sciences, Isra University, Hyderabad, Sindh, Pakistan
3 Department of Pathology, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan

Correspondence Address:
Haji Khan Khoharo
Faculty of Medicine and Allied Medical Sciences, Isra University, Hyderabad, Sindh
Pakistan

Background: Pulmonary tuberculosis (PTB) is a chronic granulomatous disease caused by Mycobacterium tuberculosis. The present study determined the serum human enolase-2 (ENO-2), high-sensitive C-reactive protein (hs-CRP), and serum cholesterol levels as biological marker of disease activity and treatment response in smear-positive drug-naïve PTB. Materials and Methods: This case–control study was done in the Department of Medicine, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro/Hyderabad, Sindh, from January 2015 to April 2016. Thirty-five sputum smear-positive drug-naïve PTB patients and thirty controls were studied. MTB culture and drug sensitivity were performed at the Diagnostic and Research Laboratory of LUMHS. Serum ENO-2, hs-CRP, and serum cholesterol were estimated at baseline, 3rd and 6th month of antituberculosis (TB) therapy. Results: Serum ENO-2 and hs-CRP were found raised in PTB compared to controls and showed decrease of 13% and 21.55%, 19.6% and 31.5% at 3rd and 6th month, respectively (P = 0.0001). Serum ENO-2 revealed positive correlation with hs-CRP (r = 0.734, P= 0.0001), and serum cholesterol revealed negative correlation with ENO-2 and hs-CRP (r = −0.509, P= 0.0001) and (r = −0.566, P= 0.0001), respectively. Conclusion: The present study reports the baseline ENO-2 and hs-CRP were raised, and serum cholesterol was low in smear-positive PTB patients and the ENO-2 and hs-CRP were reduced by anti-TB drug therapy.


How to cite this article:
Almani SA, Shaikh TZ, Khoharo HK, Ujjan I. Serum enolase-2, high-sensitivity C-reactive protein, and serum cholesterol in smear-positive drug-naïve pulmonary tuberculosis.J Res Med Sci 2017;22:49-49


How to cite this URL:
Almani SA, Shaikh TZ, Khoharo HK, Ujjan I. Serum enolase-2, high-sensitivity C-reactive protein, and serum cholesterol in smear-positive drug-naïve pulmonary tuberculosis. J Res Med Sci [serial online] 2017 [cited 2021 Feb 28 ];22:49-49
Available from: https://www.jmsjournal.net/article.asp?issn=1735-1995;year=2017;volume=22;issue=1;spage=49;epage=49;aulast=Almani;type=0